Description

Book Synopsis
The current resurgence of tuberculosis (TB) is being sustained and fuelled by the increasing incidence of resistance of M tuberculosis strains to the most-effective (first-line) anti-TB drugs and association of active TB disease with concomitant human immunodeficiency virus (HIV) infection or other underlying immunosuppressive conditions such as diabetes. In this book, the authors study the risk factors, drug resistance data and treatment methods for tuberculosis. Topics discussed include the global burden of TB and its public health crisis; new medicines to treat TB; rapid microcalorimetric detection of TB; meta-analysis and risk factors for tuberculosis susceptibility; Type 2 diabetes as a risk factor for TB; and elucidating the action mode of the bi-substrate InhA inhibitors as anti-tuberculosis agents through molecular dynamics simulations.

Tuberculosis: Risk Factors, Drug Resistance &

    Product form

    £149.99

    Includes FREE delivery

    RRP £199.99 – you save £50.00 (25%)

    Order before 4pm tomorrow for delivery by Fri 26 Jun 2026.

    A Hardback by Scott E Walker, David F Martin

    1 in stock

      Trusted by thousands of customers. See 2,385+ Customer Reviews

      View other formats and editions of Tuberculosis: Risk Factors, Drug Resistance & by Scott E Walker

      Publisher: Nova Science Publishers Inc
      Publication Date: 01/01/2013
      ISBN13: 9781620819913, 978-1620819913
      ISBN10: 1620819910
      Also in:
      Infectious and contagious diseases

      Description

      Book Synopsis
      The current resurgence of tuberculosis (TB) is being sustained and fuelled by the increasing incidence of resistance of M tuberculosis strains to the most-effective (first-line) anti-TB drugs and association of active TB disease with concomitant human immunodeficiency virus (HIV) infection or other underlying immunosuppressive conditions such as diabetes. In this book, the authors study the risk factors, drug resistance data and treatment methods for tuberculosis. Topics discussed include the global burden of TB and its public health crisis; new medicines to treat TB; rapid microcalorimetric detection of TB; meta-analysis and risk factors for tuberculosis susceptibility; Type 2 diabetes as a risk factor for TB; and elucidating the action mode of the bi-substrate InhA inhibitors as anti-tuberculosis agents through molecular dynamics simulations.

      Recently viewed products

      © 2026 Book Curl

        • American Express
        • Apple Pay
        • Diners Club
        • Discover
        • Google Pay
        • Maestro
        • Mastercard
        • PayPal
        • Shop Pay
        • Union Pay
        • Visa

        Login

        Forgot your password?

        Don't have an account yet?
        Create account